Web-based application for predicting the potential target phenotype for recombinant human thrombomodulin therapy in patients with sepsis: analysis of three multicentre registries

A recent randomised controlled trial failed to demonstrate a beneficial effect of recombinant human thrombomodulin (rhTM) on sepsis. However, there is still controversy in the effects of rhTM for sepsis due to the heterogeneity of the study population. We previously identified patients with a distin...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Tadahiro, Kudo, Daisuke, Uchimido, Ryo, Hayakawa, Mineji, Yamakawa, Kazuma, Abe, Toshikazu, Shiraishi, Atsushi, Kushimoto, Shigeki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121613/
https://www.ncbi.nlm.nih.gov/pubmed/35590381
http://dx.doi.org/10.1186/s13054-022-04020-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121613/
https://www.ncbi.nlm.nih.gov/pubmed/35590381
http://dx.doi.org/10.1186/s13054-022-04020-1

Ejemplares similares